EMRELIS (telisotuzumab vedotin-tllv)
ANTINEOPLASTIC MONOCLONAL ANTIBODIES · NON-SQUAMOUS NON-SMALL CELL LUNG CANCER (NSCLC) WITH HIGH C-MET PROTEIN OVEREXPRESSION
ABBOTT